Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Nov 27
 +0.17 / +0.23%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+8.54% 3 years+36.59%
3 months-2.35% 5 years+30.07%
1 year+22.08% Since inception+16.76%
Data through 11/28/2015

Quote Details

Previous close$72.45
Open day’s range72.33 – 73.47
Net asset value (NAV)73.03 (11/27/2015)
Daily volume1,540,976
Average volume (3 months)5,178,856
Data as of 12:59pm ET, 11/27/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+30.07%+20.45%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.061.34
Net assets$2.3B$1.7B
Average market cap$2.1B$35.0B
Average P/E--24.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
FPRX Five Prime Therapeutics Inc1.78%
JUNO Juno Therapeutics Inc1.44%
OREX Orexigen Therapeutics Inc1.44%
DYAX Dyax Corp1.39%
INFI Infinity Pharmaceuticals Inc1.36%
ONCE Spark Therapeutics Inc1.35%
MGNX MacroGenics Inc1.35%
ACOR Acorda Therapeutics Inc1.26%
ZIOP ZIOPHARM Oncology Inc1.24%
KITE Kite Pharma Inc1.24%